Close

Notable Analyst Rating Changes 1/23: MRK, BBT, SIAL, JCG Upgraded; CME, PBR, AMD, MSCC Downgraded

January 23, 2009 9:58 AM EST Send to a Friend
UPGRADES:
Merrill Lynch upgrades Merck (NYSE: MRK) upgraded from Neutral to Buy, citing valuation.

Keefe, Bruyette and Woods upgrades ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login